In a study involving a tumor-bearing animal model with PD-1 inhibitor resistance, radiotherapy and PD-1 inhibitor were administered simultaneously to block the IFN-β pathway, and it was discovered that this combination was unable to exhibit the original anti-tumor22. This evidence concerns the gene PDCD1 and neoplasm.